TY - JOUR
T1 - Reduced Expression of Uncoupling Protein 2 in Adipose Tissue in Patients with Hypothyroidism
AU - Gjedde, Signe
AU - Gormsen, Lars Christian
AU - Riis, Anne Lene Dalkjaer
AU - Jørgensen, Jens Otto Lunde
AU - Rungby, Jørgen
AU - Møller, Niels
AU - Weeke, Jørgen
AU - Pedersen, Steen Bønløkke
PY - 2010/7
Y1 - 2010/7
N2 - CONTEXT: Thyroid disease is associated with major metabolic changes, comprising changes in lipid metabolism. Thyroid hormones have previously been shown to increase UCP2 mRNA expression in fat biopsies from hyperthyroid patients, but data from hypothyroid patients have so far not been reported.PATIENTS AND METHODS: Eleven hypothyroid patients were studied before and after l-T(4) replacement, and 10 healthy controls matched for sex, age, and body mass index were studied once. Subcutaneous fat biopsies were performed, and UCP2 mRNA expression was measured in these biopsies. Patients also underwent indirect calorimetry and blood sampling.RESULTS: Patients were profoundly hypothyroid at study entry with significantly increased TSH levels (149.9 + or - 60.4 mU/liter). UCP2 mRNA expression was reduced in the hypothyroid state as compared with the euthyroid state (0.0081 + or - 0.0028 vs. 0.0420 + or - 0.0076, P < 0.01). Using pooled data from hypothyroid patients and control subjects, we found positive correlations between lipid oxidation rates and adipose tissue UCP2 expression (r = 0.63; P < 0.004), basal free fatty acid levels and UCP2 expression (r = 0.51; P < 0.03), and T(3) levels and UCP2 (r = 0.69; P < 0.001).CONCLUSION: Our study demonstrates that hypothyroidism is associated with a profound decrease in UCP2 mRNA expression. It supports the notion that UCP2 is a determinant of fat oxidation pathways and may be involved in the changes seen in the metabolic pathways in thyroid disease.
AB - CONTEXT: Thyroid disease is associated with major metabolic changes, comprising changes in lipid metabolism. Thyroid hormones have previously been shown to increase UCP2 mRNA expression in fat biopsies from hyperthyroid patients, but data from hypothyroid patients have so far not been reported.PATIENTS AND METHODS: Eleven hypothyroid patients were studied before and after l-T(4) replacement, and 10 healthy controls matched for sex, age, and body mass index were studied once. Subcutaneous fat biopsies were performed, and UCP2 mRNA expression was measured in these biopsies. Patients also underwent indirect calorimetry and blood sampling.RESULTS: Patients were profoundly hypothyroid at study entry with significantly increased TSH levels (149.9 + or - 60.4 mU/liter). UCP2 mRNA expression was reduced in the hypothyroid state as compared with the euthyroid state (0.0081 + or - 0.0028 vs. 0.0420 + or - 0.0076, P < 0.01). Using pooled data from hypothyroid patients and control subjects, we found positive correlations between lipid oxidation rates and adipose tissue UCP2 expression (r = 0.63; P < 0.004), basal free fatty acid levels and UCP2 expression (r = 0.51; P < 0.03), and T(3) levels and UCP2 (r = 0.69; P < 0.001).CONCLUSION: Our study demonstrates that hypothyroidism is associated with a profound decrease in UCP2 mRNA expression. It supports the notion that UCP2 is a determinant of fat oxidation pathways and may be involved in the changes seen in the metabolic pathways in thyroid disease.
KW - Absorptiometry, Photon
KW - Adipose Tissue
KW - Body Composition
KW - Body Mass Index
KW - Calorimetry, Indirect
KW - Fatty Acids, Nonesterified
KW - Female
KW - Humans
KW - Hypothyroidism
KW - Immunoassay
KW - Ion Channels
KW - Male
KW - Mitochondrial Proteins
KW - RNA, Messenger
KW - Reverse Transcriptase Polymerase Chain Reaction
KW - Statistics, Nonparametric
KW - Thyroxine
KW - Triiodothyronine
U2 - 10.1210/jc.2009-0907
DO - 10.1210/jc.2009-0907
M3 - Journal article
C2 - 20427509
SN - 0021-972X
VL - 95
SP - 3537
EP - 3541
JO - The Journal of clinical endocrinology and metabolism
JF - The Journal of clinical endocrinology and metabolism
IS - 7
ER -